Johnson & Johnson
Soft chewable dosage form

Last updated:

Abstract:

The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form.

Status:
Grant
Type:

Utility

Filling date:

16 Oct 2019

Issue date:

12 Oct 2021